BioCardia Inc (BCDA)
2.94
+0.18
(+6.52%)
USD |
NASDAQ |
Sep 27, 16:00
2.91
-0.03
(-1.02%)
After-Hours: 20:00
BioCardia Cash from Operations (Quarterly): -1.312M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.312M |
| March 31, 2024 | -1.53M |
| December 31, 2023 | -1.851M |
| September 30, 2023 | -2.412M |
| June 30, 2023 | -3.151M |
| March 31, 2023 | -2.56M |
| December 31, 2022 | -2.997M |
| September 30, 2022 | -2.006M |
| June 30, 2022 | -2.645M |
| March 31, 2022 | -2.913M |
| December 31, 2021 | -2.975M |
| September 30, 2021 | -2.643M |
| June 30, 2021 | -2.865M |
| March 31, 2021 | -1.883M |
| December 31, 2020 | -3.417M |
| September 30, 2020 | -3.604M |
| June 30, 2020 | -2.343M |
| March 31, 2020 | -2.993M |
| December 31, 2019 | -3.256M |
| September 30, 2019 | -1.472M |
| June 30, 2019 | -2.252M |
| March 31, 2019 | -2.465M |
| December 31, 2018 | -3.246M |
| September 30, 2018 | -2.009M |
| June 30, 2018 | -2.778M |
| Date | Value |
|---|---|
| March 31, 2018 | -3.036M |
| December 31, 2017 | -2.525M |
| September 30, 2017 | -1.777M |
| June 30, 2017 | -2.091M |
| March 31, 2017 | -2.278M |
| December 31, 2016 | -11.12M |
| September 30, 2016 | 5.565M |
| June 30, 2016 | -0.053M |
| March 31, 2016 | 0.085M |
| December 31, 2015 | 0.114M |
| September 30, 2015 | 0.038M |
| June 30, 2015 | 0.09M |
| March 31, 2015 | 0.089M |
| December 31, 2014 | 0.053M |
| September 30, 2014 | 0.055M |
| June 30, 2014 | 0.079M |
| March 31, 2014 | 0.027M |
| December 31, 2013 | 0.032M |
| September 30, 2013 | -0.006M |
| June 30, 2013 | 0.015M |
| March 31, 2013 | -0.014M |
| December 31, 2012 | 0.445M |
| September 30, 2012 | -0.061M |
| June 30, 2012 | -0.668M |
| March 31, 2012 | -0.026M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-3.604M
Minimum
Sep 2020
-1.312M
Maximum
Jun 2024
-2.541M
Average
-2.644M
Median
Cash from Operations (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 124.16M |
| Theriva Biologics Inc | -3.452M |
| Zevra Therapeutics Inc | -19.11M |
| PetIQ Inc | 57.88M |
| Instil Bio Inc | -10.61M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.003M |
| Cash from Financing (Quarterly) | 1.787M |
| Free Cash Flow | -7.108M |
| Free Cash Flow Per Share (Quarterly) | -0.7006 |
| Free Cash Flow to Equity (Quarterly) | -1.315M |
| Free Cash Flow Yield | -148.9% |